Načítá se...
Osteosarcoma: Cells-of-Origin, Cancer Stem Cells, and Targeted Therapies
Osteosarcoma (OS) is the most common type of primary solid tumor that develops in bone. Although standard chemotherapy has significantly improved long-term survival over the past few decades, the outcome for those patients with metastatic or recurrent OS remains dismally poor and, therefore, novel a...
Uloženo v:
| Vydáno v: | Stem Cells Int |
|---|---|
| Hlavní autoři: | , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Hindawi Publishing Corporation
2016
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4913005/ https://ncbi.nlm.nih.gov/pubmed/27366153 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2016/3631764 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|